Guangzhou Baiyunshan Pharmaceutical Holdings (00874): The injection of dextroamphetamine sulfate (1ml:2mg) has passed the consistency evaluation of generic drugs.
Baiyunshan (00874) announced that recently, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company")s wholly-owned subsidiary Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. (hereinafter referred to as "Mingxing Pharmaceuticals") has received the "Notice of Approval for Supplementary Application of Drugs" issued by the National Medical Products Administration, stating that the injection of racemic epinephrine tartrate (1ml:2mg) has passed the consistency evaluation of quality and efficacy for generic drugs.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) released an announcement stating that recently, Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company")'s wholly-owned subsidiary Guangzhou Baiyunshan Pharmaceutical Holdings Mingxing Pharmaceutical Co., Ltd. (hereinafter referred to as "Mingxing Pharmaceutical") received the "Approval Notice for Supplemental Drug Application" issued by the National Medical Products Administration, indicating that the injection of racemic norepinephrine tartrate (1ml:2mg) has passed the consistency evaluation of the quality and efficacy of generic drugs.
Related Articles
STAR SPORTS MED (01609): Selected for Inclusion in the Hang Seng Composite Index Constituents
ESSEX BIO-TECH (01061) spent HKD 90,600 on August 24 to repurchase 40,000 shares.
DYNAM JAPAN (06889) spent HKD 1.5744 million on August 24 to repurchase 500,000 shares.
STAR SPORTS MED (01609): Selected for Inclusion in the Hang Seng Composite Index Constituents
ESSEX BIO-TECH (01061) spent HKD 90,600 on August 24 to repurchase 40,000 shares.
DYNAM JAPAN (06889) spent HKD 1.5744 million on August 24 to repurchase 500,000 shares.
RECOMMEND
